Published in N Engl J Med on October 09, 1997
Investing in youth tobacco control: a review of smoking prevention and control strategies. Tob Control (2000) 4.19
Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA. Tob Control (2000) 3.55
A systematic review of interventions for preventing tobacco sales to minors. Tob Control (2000) 3.23
Effects of sixty six adolescent tobacco use cessation trials and seventeen prospective studies of self-initiated quitting. Tob Induc Dis (2002) 3.07
The effects of community policies to reduce youth access to tobacco. Am J Public Health (1998) 2.99
State laws on youth access to tobacco in the United States: measuring their extensiveness with a new rating system. Tob Control (1998) 2.85
Racial/ethnic differences in cigarette smoking initiation and progression to daily smoking: a multilevel analysis. Am J Public Health (2004) 2.79
Tobacco point of sale advertising increases positive brand user imagery. Tob Control (2002) 2.65
Sources of tobacco for youths in communities with strong enforcement of youth access laws. Tob Control (2001) 2.13
Mediation designs for tobacco prevention research. Drug Alcohol Depend (2002) 2.12
Long-term effects of laws governing youth access to tobacco. Am J Public Health (2013) 1.60
Enforcement of underage sales laws as a predictor of daily smoking among adolescents: a national study. BMC Public Health (2009) 1.40
Tobacco outlet density, retailer cigarette sales without ID checks and enforcement of underage tobacco laws: associations with youths' cigarette smoking and beliefs. Addiction (2015) 1.40
The first decade of the Massachusetts Tobacco Control Program. Public Health Rep (2005) 1.39
Effects of undercover police stings of gun dealers on the supply of new guns to criminals. Inj Prev (2006) 1.32
Effects of a gun dealer's change in sales practices on the supply of guns to criminals. J Urban Health (2006) 1.23
Cigarette taxes and smoking during pregnancy. Am J Public Health (2001) 1.20
Which adults do underaged youth ask for cigarettes? Am J Public Health (1999) 1.18
Cigarette acquisition and proof of age among US high school students who smoke. Tob Control (2002) 1.16
The ID effect on youth access to cigarettes. Tob Control (2002) 1.09
Effect of policies directed at youth access to smoking: results from the SimSmoke computer simulation model. Tob Control (2001) 1.07
Relation between access to tobacco and adolescent smoking. Tob Control (2004) 1.06
Is the standard compliance check protocol a valid measure of the accessibility of tobacco to underage smokers? Tob Control (2001) 1.06
Gender and ethnic differences in young adolescents' sources of cigarettes. Tob Control (1998) 1.05
Exploration of the link between tobacco retailers in school neighborhoods and student smoking. J Sch Health (2013) 1.05
Students' perception of community disapproval, perceived enforcement of school antismoking policies, personal beliefs, and their cigarette smoking behaviors: results from a structural equation modeling analysis. Nicotine Tob Res (2009) 1.01
Physician assessment of patient smoking in Indonesia: a public health priority. Tob Control (2007) 1.00
State-level tobacco control policies and youth smoking cessation measures. Health Policy (2010) 0.97
Case study of attempts to enact self service tobacco display ordinances: a tale of three communities. Tob Control (2000) 0.97
A randomized trial evaluating tobacco possession-use-purchase laws in the USA. Soc Sci Med (2008) 0.95
Media advocacy, tobacco control policy change and teen smoking in Florida. Tob Control (2007) 0.95
Cigarette smoking transition in females of low socioeconomic status: impact of state, school, and individual factors. J Epidemiol Community Health (2006) 0.94
Breaking the alliance: Defeating the tobacco industry's allies and enacting youth access restrictions in Massachusetts. Am J Public Health (2003) 0.92
The application of observational data in translational medicine: analyzing tobacco-use behaviors of adolescents. J Transl Med (2012) 0.92
The relationship between school policies and youth tobacco use. J Sch Health (2009) 0.91
Causes of the decline in cigarette smoking among African American youths from the 1970s to the 1990s. Am J Public Health (2011) 0.90
The effect of mystery shopper reports on age verification for tobacco purchases. J Health Commun (2011) 0.89
Analysis of factors related to illegal tobacco sales to young people in Ontario. Tob Control (1999) 0.89
Validity of assessments of youth access to tobacco: the familiarity effect. Am J Public Health (2003) 0.88
The impact of local U.S. tobacco policies on youth tobacco use: A critical review. Open J Prev Med (2011) 0.88
Application of consumer protection authority in preventing tobacco sales to minors. Tob Control (2002) 0.83
Cracking Down On Youth Tobacco May Influence Drug Use. J Community Psychol (2010) 0.82
Research opportunities concerning youth and the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob Res (2011) 0.77
Effects of youth tobacco access and possession policy interventions on heavy adolescent smokers. Int J Environ Res Public Health (2008) 0.76
Youth tobacco access and possession policy interventions: effects on observed and perceived tobacco use. Am J Addict (2009) 0.75
Impact of Total Vending Machine Restrictions on US Young Adult Smoking. Nicotine Tob Res (2016) 0.75
Smoking in the young. N Engl J Med (1998) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
Kaposi's sarcoma. N Engl J Med (2000) 6.81
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA (1998) 6.34
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62
Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Effect of economic reforms on child growth in urban and rural areas of China. N Engl J Med (1996) 4.50
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol (1997) 4.45
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 4.11
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
Cyclin encoded by KS herpesvirus. Nature (1996) 3.32
Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the maine lumbar spine study. Spine (Phila Pa 1976) (2000) 3.09
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
National patterns in the treatment of smokers by physicians. JAMA (1998) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun (1992) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology (1997) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Legislative efforts to protect children from tobacco. JAMA (1987) 2.57
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med (2004) 2.42
The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.41
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst (1991) 2.23
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med (1990) 2.06
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol (1996) 2.03
The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg (1997) 2.03
Rationing intensive care--physician responses to a resource shortage. N Engl J Med (1983) 2.00
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med (1998) 1.95
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88
Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med (2000) 1.88
The Tobacco Institute: helping youth say "yes" to tobacco. J Fam Pract (1992) 1.87
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med (1991) 1.85
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med (1993) 1.83
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene (2011) 1.81
Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg (2000) 1.76
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Stroke prevention in atrial fibrillation. BMJ (1997) 1.74
Patients with syncope admitted to medical intensive care units. JAMA (1982) 1.74
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72
Depression after spinal cord injury: relation to gender, ethnicity, aging, and socioeconomic indicators. Arch Phys Med Rehabil (2000) 1.72
Standards for biomedical signal databases. IEEE Eng Med Biol Mag (2001) 1.71
Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology (2011) 1.70
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (1996) 1.63
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care (2001) 1.63
The relation between expectations and outcomes in surgery for sciatica. J Gen Intern Med (1999) 1.62
Standards of care for diabetes. Diabetes Care (1994) 1.59
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination. Clin Infect Dis (1999) 1.59
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59